Network Biology is an innovative and integrative discipline combining computational modeling, high-throughput in vitro experimentation, protein engineering and  biological expertise. Merrimack is the only company that has brought together the technologies, people, and expertise necessary to apply this approach in a commercial setting.

We use Network Biology to improve early strategic decision making which results in lower attrition rates later on.  

Our research is centered on the development of detailed computational models of the biochemical pathways involved in disease. These models form the foundation of our decision making process and yield significant improvements in drug design and decision making throughout the development of our therapeutics.

For more detailed information on our Network Biology platform, please click on the links below:

[ back to top ]